Leukemia Clinical Trials

Showing 2541-2560 of 10,987 trials

A Biomarker Screening Protocol for Participants With Solid Tumors

NCT05891197

Biomarker Screening Protocol for Preliminary Eligibility Determination for Adoptive T-cell Therapy Trials:This is a decentralized, multi-site, US-based biomarker screening study to identify participants who have specific disease indications and tumor expression of target(s) of interest that may inform eligibility for active and future Lyell clinical trials. No investigational treatments will be administered in this non-interventional screening study. Only previously obtained archival tumor tissue will be allowed on this study for biomarker analysis. Fresh tumor biopsies are not permitted on this study. The study will be conducted virtually and participants will utilize telehealth and e-consent modules. If participants tumors express the biomarkers of interest they can be referred to open and enrolling clinical trials. Participation on the screening study does not guarantee enrollment or treatment on an interventional clinical trial.

Triple Negative Breast CancerNon-small Cell Lung CancerNon Small Cell Lung Cancer+19 more

Lyell Immunopharma, Inc.10 participantsStarted May 2023

Rocky Mount, North Carolina, United States

RECRUITINGNA

Hypoallergenicity of a Hydrolyzed Rice Protein-based Formula in Infants and Young Children With Cow's Milk Protein Allergy

NCT06633289

The purpose of the study is to determine whether a new hydrolyzed rice protein-based formula is hypoallergenic in infants and young children with documented Immunoglobulin E (IgE)-mediated Cow Milk Protein Allergy (CMPA).

Cow's Milk Protein Allergy

Société des Produits Nestlé (SPN)67 participantsStarted Nov 2024

Berlin, Germany • Florence, Italy • Milan, Italy +8 more locations

A Biomarker Screening Protocol for Participants With Solid Tumors

Hypoallergenicity of a Hydrolyzed Rice Protein-based Formula in Infants and Young Children With Cow's Milk Protein Allergy

Related Searches

Efficacy and Safety of Egg Ladders in Children With IgE-Mediated Hen's Egg Protein Allergy

Physical Activity and Quality of Life in Childhood Cancersurvivors- a Long-term Follow-up

A Study to Assess Change in Patient Experience in Adult Participants With Chronic Lymphocytic Leukemia (CLL) Receiving Oral Venetoclax Tablets + Intravenous Rituximab or Bruton's Tyrosine Kinase Inhibitors Tablets in the United Kingdom

Atezolizumab Plus Etoposide and Platinum in Small Cell Bladder Cancer

E-Tailored Pain Management Support for Dementia Family Caregivers: Feasibility of the PACE-app

A Clinical Study Exploring Universal CAR-T Cell in Patients With Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia

"Mini Fluid Challenge Assessment: a Comparison Among Three Hemodynamic Tools"

HM2023-05: GTB-3650 Trike for High Risk MDS and R/R AML

PUFFINS Brain Health Study

A Prospective, Single-arm, Phase II Clinical Study of Tislelizumab Combined With Anlotinib and Platinum-based Doublet Perioperative Therapy for Resectable Stage II-IIIB Driver Gene-negative NSCLC

A Study to Investigate Treatment of HU and VPA, or 6-MP and VPA in Unfit AML/HR-MDS Patients

Effects of an Individual and Family Self-Management of Fall Prevention Program on Balance Ability and Fall-related Self-efficacy Among Chinese Post-Stroke Individuals

Remote Assessment of Signs and Symptoms in Palliative Care

1630GCC: Zydelig Maintenance in B-Cell Non-Hodgkin's Lymphoma After Autologous Stem Cell Transplantation

Study of Oral LY3410738 in Patients With Advanced Hematologic Malignancies With IDH1 or IDH2 Mutations

Study to Evaluate PK and Safety With Uproleselan Combined With Chemotherapy to Treat Chinese R/R AML Patients

Rifaximin for Treatment of Bloating in Children and Adults With Cystic Fibrosis

Asciminib as Maintenance Treatment After Cellular Therapies for Adults With Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia